Topics
Biology / Mechanism, Outcomes / Survival
Modality
Immunotherapy, Cell therapy, Imaging
Study type
Lab / Preclinical
Abstract
Glioblastoma remains a deadly cancer driven in part by invasion of tumor cells into the brain. Transcriptomic analyses have identified distinct molecular subtypes, but mechanistic differences that account for clinical differences are not clear. Here, we show that, as predicted by the motor-clutch model…
Authors
Shamsan, G. A., Liu, C. J., Braman, B. C., Li, R. +14
AI-generated summary
Differential migration mechanics and immune responses of glioblastoma subtypes reports: Glioblastoma remains a deadly cancer driven in part by invasion of tumor cells into the brain. Transcriptomic analyses have identified distinct molecular subtypes, but mechanistic differences that account for clinical differences are not clear. Here, we show that, as predicted by the motor-clutch model of cell migration, mesenchymal glioma cells are more spread, generate larger traction forces, and migrate faster in brain tissue compared to proneural cells. This is a preprint and not peer reviewed.
This summary may be inaccurate. Verify with the primary paper.
Primary source: bioRxiv (not peer reviewed).